Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Dose Escalation Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics Character of a Single Dose of JY1001 Injection in Healthy Adult Participants

NCT07848945 is registered in ClinicalTrials.gov with Jemincare as lead sponsor.

NCT NCT07848945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07848945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, Dose Escalation Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics Character of a Single Dose of JY1001 Injection in Healthy Adult Participants
Lead sponsor
Jemincare
Phase
Phase 1
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
May 31, 2027
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain after surgery